The TGA’s SAS-B data for 2023 reveals an increase in THC-only products’ approvals, with more women turning to flower and anxiety-related approvals on the rise. Category 5 medicines accounted for 45.2% of approvals, increasing by 21% from 2022. Men remain the major users of THC-only products but women are narrowing the gap. Victoria surpassed Queensland in SAS-B medicinal cannabis approvals.
Read the full story here
Written by: Steve Jones
Published on January 17, 2024 at 12:29PM
Source: Cannabiz (opens in new tab)